Treatment Outcomes of HIV Patients on Antiretroviral Therapy in KwaZulu-Natal, South Africa
Author Information
Author(s): Muzumbukilwa Tambwe Willy, Manimani Riziki Ghislain, Mushebenge Aganze Gloire-Aime, Vagiri Rajesh Vikram, Nlooto Manimbulu
Primary Institution: University of KwaZulu-Natal
Hypothesis
What are the treatment outcomes among individuals on highly active antiretroviral therapy in KwaZulu-Natal, South Africa?
Conclusion
The study found that while HAART is effective in achieving virological suppression and immunological recovery, the percentage of patients attaining viral suppression at 6 and 12 months was below the UNAIDS target.
Supporting Evidence
- 44.98% of patients achieved viral suppression at 6 months.
- 67.04% of patients achieved viral suppression at 12 months.
- Mortality rate was 22.63% during the study period.
- CD4 counts increased significantly over the 12 months of treatment.
- Factors associated with better outcomes included lower baseline viral load and absence of harmful behaviors.
Takeaway
This study looked at how well HIV treatment works in a place with a lot of HIV cases. It found that many people are getting better, but not enough are getting their virus levels low enough.
Methodology
This was a retrospective medical record review conducted at King Edward VIII Hospital, analyzing clinical records of patients who started ART in or after 2017.
Potential Biases
Potential biases due to incomplete medical records and the single-site nature of the study.
Limitations
The study was single-site and retrospective, with incomplete patient records leading to exclusions.
Participant Demographics
Among the 707 patients, 43% were male and 57% were female, with 56.3% aged 18–39 years.
Statistical Information
P-Value
<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website